Prognostic Significance of Modified Residual Disease in Breast and Nodes (mRDBN) Algorithm After Neoadjuvant Chemotherapy for Breast Cancer.
Department of Pathology, Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, PA.
Department of Surgery, Division of Surgical Oncology, University of Pittsburgh, Pittsburgh, PA.
Centegra Comprehensive Breast Program, Centegra Health System, Crystal Lake, IL.
College of Medicine, Department of Surgery, University of Oklahoma, Oklahoma City.
Department of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, PA.
Department of Surgery, University of Colorado, Aurora.
- Published Article
American Journal of Clinical Pathology
Oxford University Press
- Publication Date
Feb 22, 2018
Both mRDBN and gRDBN provide prognostic information, particularly in HER2-negative carcinoma; however, mRDBN showed better stratification of RDBN-3 and RDBN-4 patients.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 06/09/2018 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/29481634